mRNA-4157,Pembrolizumab
Moderna,Merck
['thanks', 'mrna-4157', 'moderna']
that's a wrap! thanks to for the opportunity to share detailed results from the phase 2b trial evaluating mrna-4157 (v940), and connect with the global cancer research community at #aacr23.
Our mission is to deliver the greatest possible impact to people through mRNA medicines.